| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Medipal Holdings Corp
|
29.131m | 23.87% | — | Sep 30 2025 |
| 2 |
Future Brain KK
|
8.711m | 7.14% | — | Sep 30 2025 |
| 3 |
Nomura Trust & Banking (Trust)
|
6.298m | 5.16% | — | Sep 30 2025 |
| 4 |
Nomura Asset Management Co., Ltd.
|
5.528m | 4.53% | -1.562m | Feb 14 2025 |
| 5 |
Kissei Pharmaceutical Co Ltd
|
4.918m | 4.03% | — | Sep 30 2025 |
|
1
Medipal Holdings Corp
|
23.87%
29.131m
|
|
2
Future Brain KK
|
7.14%
8.711m
|
|
3
Nomura Trust & Banking (Trust)
|
5.16%
6.298m
|
|
4
Nomura Asset Management Co., Ltd.
|
4.53%
5.528m
|
|
5
Kissei Pharmaceutical Co Ltd
|
4.03%
4.918m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 44.73% of Jcr Pharmaceuticals Co.,ltd., with Medipal Holdings Corp the biggest at 23.87%, followed by Future Brain KK (7.14%) and Nomura Trust & Banking (Trust) (5.16%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


